Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Other Accumulated Expenses (2021 - 2024)

Lucid Diagnostics filings provide 4 years of Other Accumulated Expenses readings, the most recent being $869000.0 for Q4 2024.

  • On a quarterly basis, Other Accumulated Expenses fell 90.69% to $869000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $869000.0, a 90.69% decrease, with the full-year FY2024 number at $869000.0, down 90.69% from a year prior.
  • Other Accumulated Expenses hit $869000.0 in Q4 2024 for Lucid Diagnostics, up from $53000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $10.3 million in Q3 2023 to a low of $53000.0 in Q3 2024.
  • Median Other Accumulated Expenses over the past 4 years was $1.4 million (2024), compared with a mean of $3.5 million.
  • Biggest five-year swings in Other Accumulated Expenses: skyrocketed 834.09% in 2022 and later crashed 99.48% in 2024.
  • Lucid Diagnostics' Other Accumulated Expenses stood at $531000.0 in 2021, then skyrocketed by 834.09% to $5.0 million in 2022, then soared by 88.29% to $9.3 million in 2023, then plummeted by 90.69% to $869000.0 in 2024.
  • The last three reported values for Other Accumulated Expenses were $869000.0 (Q4 2024), $53000.0 (Q3 2024), and $266000.0 (Q2 2024) per Business Quant data.